Literature DB >> 30318012

NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.

Keywan Mortezaee1, Nasser Hashemi Goradel2, Peyman Amini3, Dheyauldeen Shabeeb4,5, Ahmed Eleojo Musa4,6, Masoud Najafi7, Bagher Farhood8.   

Abstract

BACKGROUND: Radiotherapy is a treatment modality for cancer. For better therapeutic efficiency, it could be used in combination with surgery, chemotherapy or immunotherapy. In addition to its beneficial therapeutic effects, exposure to radiation leads to several toxic effects on normal tissues. Also, it may induce some changes in genomic expression of tumor cells, thereby increasing the resistance of tumor cells. These changes lead to the appearance of some acute reactions in irradiated organs, increased risk of carcinogenesis, and reduction in the therapeutic effect of radiotherapy. DISCUSSION: So far, several studies have proposed different targets such as cyclooxygenase-2 (COX-2), some toll-like receptors (TLRs), mitogen-activated protein kinases (MAPKs) etc., for the amelioration of radiation toxicity and enhancing tumor response. NADPH oxidase includes five NOX and two dual oxidases (DUOX1 and DUOX2) subfamilies that through the production of superoxide and hydrogen peroxide, play key roles in oxidative stress and several signaling pathways involved in early and late effects of ionizing radiation. Chronic ROS production by NOX enzymes can induce genomic instability, thereby increasing the risk of carcinogenesis. Also, these enzymes are able to induce cell death, especially through apoptosis and senescence that may affect tissue function. ROS-derived NADPH oxidase causes apoptosis in some organs such as intestine and tongue, which mediate inflammation. Furthermore, continuous ROS production stimulates fibrosis via stimulation of fibroblast differentiation and collagen deposition. Evidence has shown that in contrast to normal tissues, the NOX system induces tumor resistance to radiotherapy through some mechanisms such as induction of hypoxia, stimulation of proliferation, and activation of macrophages. However, there are some contradictory results. Inhibition of NADPH oxidase in experimental studies has shown promising results for both normal tissue protection and tumor sensitization to ionizing radiation.
CONCLUSION: In this article, we aimed to review the role of different subfamilies of NADPH oxidase in radiation-induced early and late normal tissue toxicities in different organs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  NADPH oxidase; ROS; Radiation; bystander effect; carcinogenesis; fibrosis; genomic instability; inflammation; radiotherapy; tumor resistance.

Mesh:

Substances:

Year:  2019        PMID: 30318012     DOI: 10.2174/1874467211666181010154709

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  25 in total

Review 1.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

2.  Repair characteristics and time-dependent effects in response to heavy-ion beam irradiation in Saccharomyces cerevisiae: a comparison with X-ray irradiation.

Authors:  Xiaopeng Guo; Miaomiao Zhang; Yue Gao; Dong Lu; Wenjian Li; Libin Zhou
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-06       Impact factor: 4.813

3.  The radioprotective effect of N-acetylcysteine against x-radiation-induced renal injury in rats.

Authors:  Tolga Mercantepe; Atilla Topcu; Sema Rakici; Levent Tumkaya; Adnan Yilmaz; Filiz Mercantepe
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-07       Impact factor: 4.223

Review 4.  Mechanisms of cancer cell killing by metformin: a review on different cell death pathways.

Authors:  Xiao-Yu Wu; Wen-Wen Xu; Xiang-Kun Huan; Guan-Nan Wu; Gang Li; Yu-Hong Zhou; Masoud Najafi
Journal:  Mol Cell Biochem       Date:  2022-06-30       Impact factor: 3.396

Review 5.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 6.  Nobiletin as an inducer of programmed cell death in cancer: a review.

Authors:  Jun Huang; Zaoshang Chang; Quzhe Lu; Xuedong Chen; Masoud Najafi
Journal:  Apoptosis       Date:  2022-03-21       Impact factor: 4.677

Review 7.  Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors:  Run Yang; Changming Tan; Masoud Najafi
Journal:  Inflammopharmacology       Date:  2021-11-23       Impact factor: 4.473

Review 8.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 9.  Angiogenesis as a hallmark of solid tumors - clinical perspectives.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Cell Oncol (Dordr)       Date:  2021-04-09       Impact factor: 6.730

Review 10.  Targeting of cancer cell death mechanisms by resveratrol: a review.

Authors:  Xiao Fu; Mu Li; Cuilian Tang; Zezhi Huang; Masoud Najafi
Journal:  Apoptosis       Date:  2021-09-25       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.